Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?

Vittengl JR, Clark LA, Smits JAJ, Thase ME, Jarrett RB.

J Affect Disord. 2019 Jan 1;242:150-158. doi: 10.1016/j.jad.2018.08.053. Epub 2018 Aug 25.

PMID:
30176494
2.

Methodological Recommendations for Trials of Psychological Interventions.

Guidi J, Brakemeier EL, Bockting CLH, Cosci F, Cuijpers P, Jarrett RB, Linden M, Marks I, Peretti CS, Rafanelli C, Rief W, Schneider S, Schnyder U, Sensky T, Tomba E, Vazquez C, Vieta E, Zipfel S, Wright JH, Fava GA.

Psychother Psychosom. 2018;87(5):276-284. doi: 10.1159/000490574. Epub 2018 Jul 13.

3.

Guaranteeing the quality and integrity of pork - An Australian case study.

Channon HA, D'Souza DN, Jarrett RG, Lee GSH, Watling RJ, Jolley JYC, Dunshea FR.

Meat Sci. 2018 Oct;144:186-192. doi: 10.1016/j.meatsci.2018.04.030. Epub 2018 Apr 27. Review.

PMID:
29735356
4.

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.

Hardman CS, Chen YL, Salimi M, Jarrett R, Johnson D, Järvinen VJ, Owens RJ, Repapi E, Cousins DJ, Barlow JL, McKenzie ANJ, Ogg G.

Sci Immunol. 2017 Dec 22;2(18). pii: eaan5918. doi: 10.1126/sciimmunol.aan5918.

5.

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.

Sud A, Thomsen H, Law PJ, Försti A, Filho MIDS, Holroyd A, Broderick P, Orlando G, Lenive O, Wright L, Cooke R, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL consortium, Hoffmann P, Nöthen MM, Jöckel KH, Strandmann EPV, Lightfoot T, Kane E, Roman E, Lake A, Montgomery D, Jarrett RF, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS.

Nat Commun. 2017 Dec 1;8(1):1892. doi: 10.1038/s41467-017-00320-1.

6.

Patients' comprehension and skill usage as a putative mediator of change or an engaged target in cognitive therapy: Preliminary findings.

Jarrett RB, Vittengl JR, Clark LA, Thase ME.

J Affect Disord. 2018 Jan 15;226:163-168. doi: 10.1016/j.jad.2017.09.045. Epub 2017 Sep 27.

PMID:
28987648
7.

Relations of Shared and Unique Components of Personality and Psychosocial Functioning to Depressive Symptoms.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

J Pers Disord. 2017 Sep 13:1-26. doi: 10.1521/pedi_2017_31_313. [Epub ahead of print]

PMID:
28902564
8.

Inherited Chromosomally Integrated Human Herpesvirus 6 Genomes Are Ancient, Intact, and Potentially Able To Reactivate from Telomeres.

Zhang E, Bell AJ, Wilkie GS, Suárez NM, Batini C, Veal CD, Armendáriz-Castillo I, Neumann R, Cotton VE, Huang Y, Porteous DJ, Jarrett RF, Davison AJ, Royle NJ.

J Virol. 2017 Oct 27;91(22). pii: e01137-17. doi: 10.1128/JVI.01137-17. Print 2017 Nov 15.

9.

Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.

Vittengl JR, Anna Clark L, Thase ME, Jarrett RB.

Psychiatry Res. 2017 Jul;253:174-181. doi: 10.1016/j.psychres.2017.03.032. Epub 2017 Mar 22.

10.

Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials.

Furukawa TA, Weitz ES, Tanaka S, Hollon SD, Hofmann SG, Andersson G, Twisk J, DeRubeis RJ, Dimidjian S, Hegerl U, Mergl R, Jarrett RB, Vittengl JR, Watanabe N, Cuijpers P.

Br J Psychiatry. 2017 Mar;210(3):190-196. doi: 10.1192/bjp.bp.116.187773. Epub 2017 Jan 19. Review.

11.

Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression.

Cuijpers P, Weitz E, Lamers F, Penninx BW, Twisk J, DeRubeis RJ, Dimidjian S, Dunlop BW, Jarrett RB, Segal ZV, Hollon SD.

Depress Anxiety. 2017 Mar;34(3):246-256. doi: 10.1002/da.22580. Epub 2016 Dec 6.

PMID:
27921338
12.

Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.

Waugh EM, Gallagher A, Haining H, Johnston PEJ, Marchesi F, Jarrett RF, Morris JS.

Vet Immunol Immunopathol. 2016 Dec;182:115-124. doi: 10.1016/j.vetimm.2016.10.008. Epub 2016 Oct 19.

13.

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a.

Cheung KL, Jarrett R, Subramaniam S, Salimi M, Gutowska-Owsiak D, Chen YL, Hardman C, Xue L, Cerundolo V, Ogg G.

J Exp Med. 2016 Oct 17;213(11):2399-2412. Epub 2016 Sep 26.

14.

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

Ghesquières H, Larrabee BR, Casasnovas O, Maurer MJ, McKay JD, Ansell SM, Montgomery D, Asmann YW, Farrell K, Verney A, Slager SL, Allmer C, Perrot A, Delarue R, Habermann TM, Dupuis J, Link BK, Canioni D, Dogan A, Cozen W, Jarrett RF, Cerhan JR, Salles G.

Br J Haematol. 2018 Jan;180(2):286-290. doi: 10.1111/bjh.14306. Epub 2016 Sep 9. No abstract available.

PMID:
27716907
15.

Lipid-specific T cells and the skin.

Jarrett R, Ogg G.

Br J Dermatol. 2016 Oct;175 Suppl 2:19-25. doi: 10.1111/bjd.14908. Review.

PMID:
27667311
16.

Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

Behav Res Ther. 2016 Dec;87:48-57. doi: 10.1016/j.brat.2016.08.008. Epub 2016 Aug 18.

17.

Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

J Affect Disord. 2016 Jul 15;199:148-56. doi: 10.1016/j.jad.2016.04.017. Epub 2016 Apr 13.

18.

Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.

Khankhanian P, Cozen W, Himmelstein DS, Madireddy L, Din L, van den Berg A, Matsushita T, Glaser SL, Moré JM, Smedby KE, Baranzini SE, Mack TM, Lizée A, de Sanjosé S, Gourraud PA, Nieters A, Hauser SL, Cocco P, Maynadié M, Foretová L, Staines A, Delahaye-Sourdeix M, Li D, Bhatia S, Melbye M, Onel K, Jarrett R, McKay JD, Oksenberg JR, Hjalgrim H.

Int J Epidemiol. 2016 Jun;45(3):728-40. doi: 10.1093/ije/dyv364. Epub 2016 Mar 12.

19.

HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q.

Zhang E, Cotton VE, Hidalgo-Bravo A, Huang Y, Bell AJ, Jarrett RF, Wilkie GS, Davison AJ, Nacheva EP, Siebert R, Majid A, Kelpanides I, Jayne S, Dyer MJ, Royle NJ.

Sci Rep. 2016 Mar 7;6:22730. doi: 10.1038/srep22730.

20.

Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.

Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Rush AJ, Segal ZV, Siddique J, Simons AD, Cuijpers P.

Am J Psychiatry. 2016 May 1;173(5):481-90. doi: 10.1176/appi.ajp.2015.15040492. Epub 2016 Feb 12.

21.

Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.

Jarrett R, Salio M, Lloyd-Lavery A, Subramaniam S, Bourgeois E, Archer C, Cheung KL, Hardman C, Chandler D, Salimi M, Gutowska-Owsiak D, de la Serna JB, Fallon PG, Jolin H, Mckenzie A, Dziembowski A, Podobas EI, Bal W, Johnson D, Moody DB, Cerundolo V, Ogg G.

Sci Transl Med. 2016 Feb 10;8(325):325ra18. doi: 10.1126/scitranslmed.aad6833.

22.

Thermal inactivation of Salmonella spp. in pork burger patties.

Gurman PM, Ross T, Holds GL, Jarrett RG, Kiermeier A.

Int J Food Microbiol. 2016 Feb 16;219:12-21. doi: 10.1016/j.ijfoodmicro.2015.11.014. Epub 2015 Nov 28.

PMID:
26686598
23.

Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care.

Jarrett RB, Minhajuddin A, Vittengl JR, Clark LA, Thase ME.

J Consult Clin Psychol. 2016 Apr;84(4):365-76. doi: 10.1037/ccp0000069. Epub 2015 Dec 14.

24.

Detecting Sudden Gains during Treatment of Major Depressive Disorder: Cautions from a Monte Carlo Analysis.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

Curr Psychiatry Rev. 2015 Feb 1;11(1):19-31.

25.

A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.

Delahaye-Sourdeix M, Urayama KY, Gaborieau V, Veenstra R, Foll M, Chabrier A, Benavente Y, Nieters A, Becker N, Foretova L, Maynadié M, Staines A, Smedby KE, Glimelius I, Lightfoot T, Cocco P, Galan P, Vatten LJ, Duell EJ, Kiemeney L, Roman E, de Sanjosé S, Lathrop M, Melbye M, Brennan P, Diepstra A, van den Berg A, Hjalgrim H, Jarrett RF, McKay JD.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1838-43. doi: 10.1158/1055-9965.EPI-15-0534. Epub 2015 Sep 24.

26.

Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.

Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Cristea IA, Faramarzi M, Hegerl U, Jarrett RB, Kheirkhah F, Kennedy SH, Mergl R, Miranda J, Mohr DC, Rush AJ, Segal ZV, Siddique J, Simons AD, Vittengl JR, Cuijpers P.

JAMA Psychiatry. 2015 Nov;72(11):1102-9. doi: 10.1001/jamapsychiatry.2015.1516.

PMID:
26397232
27.

Improving the pathologic evaluation of lung cancer resection specimens.

Osarogiagbon RU, Hilsenbeck HL, Sales EW, Berry A, Jarrett RW Jr, Giampapa CS, Finch-Cruz CN, Spencer D.

Transl Lung Cancer Res. 2015 Aug;4(4):432-7. doi: 10.3978/j.issn.2218-6751.2015.07.07.

28.

Assessing cognitive therapy skills comprehension, acquisition, and use by means of an independent observer version of the Skills of Cognitive Therapy (SoCT-IO).

Brown GK, Thase ME, Vittengl JR, Borman PD, Clark LA, Jarrett RB.

Psychol Assess. 2016 Feb;28(2):205-13. doi: 10.1037/pas0000080. Epub 2015 Sep 7.

29.

"So we would all help pitch in:" The family literacy practices of low-income African American mothers of preschoolers.

Jarrett RL, Hamilton MB, Coba-Rodriguez S.

J Commun Disord. 2015 Sep-Oct;57:81-93. doi: 10.1016/j.jcomdis.2015.07.003. Epub 2015 Jul 22.

PMID:
26338290
30.

Human leukocyte antigens and genetic susceptibility to lymphoma.

McAulay KA, Jarrett RF.

Tissue Antigens. 2015 Aug;86(2):98-113. doi: 10.1111/tan.12604. Review.

PMID:
26189878
31.

Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

Psychol Med. 2015 Nov;45(15):3191-204. doi: 10.1017/S0033291715001191. Epub 2015 Jun 22.

32.

Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

Psychotherapy (Chic). 2015 Jun;52(2):268-77. doi: 10.1037/pst0000021.

33.

A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.

Bockting CL, Hollon SD, Jarrett RB, Kuyken W, Dobson K.

Clin Psychol Rev. 2015 Nov;41:16-26. doi: 10.1016/j.cpr.2015.02.003. Epub 2015 Feb 26. Review.

PMID:
25754289
34.

Cognitive Therapy to Prevent Depressive Relapse in Adults.

Vittengl JR, Jarrett RB.

Curr Opin Psychol. 2015 Aug 1;4:26-31.

35.

Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas.

Waugh EM, Gallagher A, McAulay KA, Henriques J, Alves M, Bell AJ, Morris JS, Jarrett RF.

J Gen Virol. 2015 Jul;96(Pt 7):1863-72. doi: 10.1099/vir.0.000106. Epub 2015 Feb 26.

36.

Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.

Johnson PC, McAulay KA, Montgomery D, Lake A, Shield L, Gallagher A, Little AM, Shah A, Marsh SG, Taylor GM, Jarrett RF.

Int J Cancer. 2015 Sep 1;137(5):1066-75. doi: 10.1002/ijc.29467. Epub 2015 Feb 20.

37.

Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.

Cuijpers P, Weitz E, Twisk J, Kuehner C, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Jarrett RB, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Segal ZV, Siddique J, Simons AD, Vittengl JR, Hollon SD.

Depress Anxiety. 2014 Nov;31(11):941-51. doi: 10.1002/da.22328.

PMID:
25407584
38.

Germ-line transmitted, chromosomally integrated HHV-6 and classical Hodgkin lymphoma.

Bell AJ, Gallagher A, Mottram T, Lake A, Kane EV, Lightfoot T, Roman E, Jarrett RF.

PLoS One. 2014 Nov 10;9(11):e112642. doi: 10.1371/journal.pone.0112642. eCollection 2014.

39.

Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.

Jha MK, Minhajuddin A, Thase ME, Jarrett RB.

J Affect Disord. 2014;167:37-43. doi: 10.1016/j.jad.2014.05.038. Epub 2014 Jun 2.

40.

Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

J Consult Clin Psychol. 2014 Dec;82(6):1049-59. doi: 10.1037/a0037401. Epub 2014 Jul 21.

41.

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Cozen W, Timofeeva MN, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Franke L, Rostgaard K, Van Den Berg DJ, Cortessis VK, Smedby KE, Glaser SL, Westra HJ, Robison LL, Mack TM, Ghesquieres H, Hwang AE, Nieters A, de Sanjose S, Lightfoot T, Becker N, Maynadie M, Foretova L, Roman E, Benavente Y, Rand KA, Nathwani BN, Glimelius B, Staines A, Boffetta P, Link BK, Kiemeney L, Ansell SM, Bhatia S, Strong LC, Galan P, Vatten L, Habermann TM, Duell EJ, Lake A, Veenstra RN, Visser L, Liu Y, Urayama KY, Montgomery D, Gaborieau V, Weiss LM, Byrnes G, Lathrop M, Cocco P, Best T, Skol AD, Adami HO, Melbye M, Cerhan JR, Gallagher A, Taylor GM, Slager SL, Brennan P, Coetzee GA, Conti DV, Onel K, Jarrett RF, Hjalgrim H, van den Berg A, McKay JD.

Nat Commun. 2014 Jun 12;5:3856. doi: 10.1038/ncomms4856.

42.

Extreme nonresponse to acute phase cognitive therapy for depression: an attempt to replicate and extend.

Koenig AM, Jarrett RB, Gallop R, Barrett MS, Thase ME.

Behav Ther. 2014 May;45(3):300-13. doi: 10.1016/j.beth.2013.12.005. Epub 2013 Dec 23.

44.

Commentary: professor Harry Keen, clinician, epidemiologist, diabetologist, basic scientist and defender of the UK National Health Service.

Jarrett RJ.

Int J Epidemiol. 2014 Feb;43(1):16-8. doi: 10.1093/ije/dyt254. Epub 2013 Dec 30. No abstract available.

PMID:
24381010
45.

The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics: II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels.

Keen H, Chlouverakis C, Fuller J, Jarrett RJ.

Int J Epidemiol. 2014 Feb;43(1):11-5. doi: 10.1093/ije/dyt257. Epub 2013 Dec 30.

PMID:
24381008
46.

Passing on knowledge and skills gave me a sense of fulfillment.

Jarrett R.

Nurs Stand. 2013 Nov 20-26;28(12):37. doi: 10.7748/ns2013.11.28.12.37.s47. No abstract available.

PMID:
24251511
47.

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.

Frampton M, da Silva Filho MI, Broderick P, Thomsen H, Försti A, Vijayakrishnan J, Cooke R, Enciso-Mora V, Hoffmann P, Nöthen MM, Lloyd A, Holroyd A, Eisele L, Jöckel KH, Ponader S, von Strandmann EP, Lightfoot T, Roman E, Lake A, Montgomery D, Jarrett RF, Swerdlow AJ, Engert A, Hemminki K, Houlston RS.

Nat Commun. 2013;4:2549. doi: 10.1038/ncomms3549.

48.

Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME.

JAMA Psychiatry. 2013 Nov;70(11):1152-60. doi: 10.1001/jamapsychiatry.2013.1969.

49.

Replication and extension: separate personality traits from states to predict depression.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

J Pers Disord. 2014 Apr;28(2):225-46. doi: 10.1521/pedi_2013_27_117. Epub 2013 Jun 20.

50.

Leave the nurse station where it is and address staffing levels.

Jarrett R.

Nurs Stand. 2013 May 8;27(36):31-32.

PMID:
26981830

Supplemental Content

Loading ...
Support Center